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Kidney  structure  was  compared  in  young  mice  with  and  without  chronic  lead  exposure.
Mice  with  blood  lead  levels  2.4–4.7  g/dl  had  increased  glomerular  volumes.
Glomerular  volume  increase  was  the  result  of  capillary  and mesangial  volume  increases.
Mice  with  blood  lead  levels  11.7–20.3  g/dl  did not  have  glomerular  volume  changes.
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a  b  s  t  r  a  c  t
Early  chronic  lead  exposure  continues  to  pose  serious  health  risks  for  children,  particularly  those  living
in lower  socioeconomic  environments.  This  study  examined  effects  on  developing  glomeruli  in young
C57BL/6J  mice  exposed  to low  (30 ppm),  higher  (330  ppm)  or no  lead via  dams’  drinking  water  from  birth
to  sacriﬁce  on  post-natal  day  28.  Low-level  lead  exposed  mice [BLL  mean  (SD);  3.19 (0.70)  g/dL]  had
an  increase  in glomerular  volume  but  no change  in  podocyte  number  compared  to control  mice  [0.03
(0.01)  g/dL].  Higher-level  lead exposed  mice  [14.68  (2.74)  g/dL]  had  no  change  in either glomerulareywords:
b toxicity
lomerular hypertrophy
apillary volume
esangial volume
volume  or  podocyte  number.  The  increase  in glomerular  volume  was  explained  by increases  in  glomerular
capillary  and mesangial  volumes  with  no  change  in podocyte  volume.  Early  chronic  lead exposure  yielding
very  low  blood  lead  levels  alters  glomerular  development  in  pre-adolescent  animals.
© 2013 The Authors. Published by Elsevier Ireland Ltd. Open access under CC BY-NC-ND license.esign-based stereology
. Introduction
Exposure to lead has affected humans for millennia. Despite a
ramatic reduction of environmental lead in the United States over
he past 40 years, high levels persist in many lower socioeconomic
eighborhoods (Lanphear et al., 2002). Child research has helped
o increase recognition that no level of lead exposure is safe for
hildren, and clinical studies have repeatedly shown the ill-effects
f developmental lead exposure on organ systems.
∗ Corresponding author. Tel.: +1 3233573668.
E-mail addresses: johnbasgen@cdrewu.edu, basgen@umn.edu (J.M. Basgen),
asobin@utep.edu (C. Sobin).
378-4274/© 2013 The Authors. Published by Elsevier Ireland Ltd. 
ttp://dx.doi.org/10.1016/j.toxlet.2013.11.031
Open access under CC BY-The ﬁrst report of an association between lead exposure and
kidney disease was more than one hundred years ago and has been
followed by many subsequent reports (de Burbure et al., 2006; Fels
et al., 1998; Steenland et al., 1992). For many years, the link between
lead exposure and kidney disease was  controversial. While ﬁndings
from some reports suggested a direct relationship between kid-
ney disease and lead exposure (Ekong et al., 2006; Fadrowski et al.,
2010), others suggested that preexisting kidney disease prevented
adequate excretion of ingested or inhaled lead thus increasing
blood and body lead burden and its deleterious effects (Staessen
et al., 1990). Some of the controversy may  have been due to the
broad variability in lead exposure levels examined and age related
differences in lead metabolism (Lidsky and Schneider, 2003). Lead
absorption is greater and retention is longer in children as com-
pared to adults (Ziegler et al., 1978). Also, exposure during early
development may  affect kidneys differently than exposure during
late adolescence or adulthood. More recently, studies have con-
ﬁrmed the association between lead exposure and kidney damage
NC-ND license.
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Spector et al., 2011), and a few have suggested adverse effects of
ery low-level lead exposure on developing kidney. Glomerular ﬁl-
ration rate (GFR) is a measure of kidney function and is used to
iagnose kidney injury and failure. GFR is a well-established indica-
or of early-stage diabetic nephropathy, hypertensive nephropathy,
nd other renal diseases. For example, recent studies showed
hat GFR was elevated even in pre-diabetics and pre-hypertensive
atients (Fadrowski et al., 2010; Okada et al., 2012). Progressive
idney disease has been shown to be characterized by a decrease
o abnormally low GFR followed by eventual glomerulosclerosis
Palatini et al., 2012). Increased GFR is associated with glomerular
ypertrophy in both diabetic patients and animal models of dia-
etes (Østerby and Gundersen, 1975; Seyer-Hansen et al., 1980). It
as been hypothesized that stress within hypertrophic glomeruli
nitiates changes in the glomerulus resulting in glomerulosclerosis
Nagata et al., 1992).
Kidney development results from a complex interaction of
iverse metabolic pathways that are dependent on transcription
actors, cytokines, growth factors, angiotensin II, and other con-
ributing processes (Cain et al., 2010; Carroll and Das, 2013).
idney development occurs as the ureteric bud undergoes repeated
ranching, with each branch point meeting metanephric mes-
nchyme. This branching process produces four morphologically
istinguishable stages of glomerular development including the
omma-shaped body, s-shaped body, capillary loop stage, and
ature glomerulus (Reeves et al., 1978). Disruption of devel-
pment during any of these stages may  produce maldeveloped
idneys, which may  in turn result in low body weight, low glomeru-
ar number, and glomerular hypertrophy at birth; and notably,
ypertension and kidney disease later in life (Keller et al., 2003;
chreuder, 2012). Early lead exposure may  disrupt glomerular
evelopment which could manifest as hypertension and kidney
isease later in life long after lead has cleared from the body. Such
ffects might partially explain high rates of idiopathic kidney dis-
ase that have observed in speciﬁc minority populations (Hsu et al.,
003) living in lower socioeconomic neighborhoods with increased
ikelihood of environmental lead exposure.
Animal studies have not yet examined effects on kidney struc-
ure of chronic low-level developmental lead exposure. In rodent
idney, where glomerulogenesis and glomerular development con-
inue for several weeks after birth (Ciuffo et al., 1993), chronic
ost-partum exposure to lead could provide a model of low-level
ead induced nephrotoxicity, including glomerular maldevelop-
ent. The aim of these studies was to examine whether chronic
xposure to lead in young C57BL/6J mice resulted in maldeveloped
lomeruli. If so, the ﬁndings could suggest a model for studying pos-
ible links between early chronic exposure to lead and hypertension
nd kidney disease in adulthood.
. Materials and methods
.1. Animals
C57BL/6J (Jax Mice, Jackson Laboratory, Sacramento, CA) were
red and housed at the University of Texas at El Paso Bio-
ciences Research Facility vivarium. Individual litters were kept in
olycarbonate cages with wood chip bedding. The mice were main-
ained on a 12 h light–dark schedule at a temperature of 21 ± 2 ◦C
ith ad libitum access to food and water. The drinking water of
he dams was treated with 99.4% lead acetate. No invasive proce-
ures were conducted during the 28-day exposure time. Natural
itters were exposed from birth to one of three lead doses: 0, 30, or
30 ppm, selected after pilot studies demonstrated that 30–40 ppm
f lead acetate in dams’ drinking water yielded a range of blood lead
evels that overlapped those of approximately 60% of low-income Letters 225 (2014) 48– 56 49
children tested in our child lead exposure studies (unpublished
data). Twelve mice per group (six male and six female) were
used for analysis. This study was  carried out following a protocol
approved by the Animal Care and Use Committee of the Univer-
sity of Texas at El Paso (NIH Assurance #A3340-01) in accordance
with the Guide for the Care and Use of Laboratory Animals of the
National Institutes of Health.
2.2. Analysis of blood lead
Mice were anesthetized with Avertin at post-natal day 28 (PND
28). When full anesthesia was conﬁrmed (via absence of blink
response and paw-pinch reﬂexes) the chest cavity was opened and
50 l of blood was drawn from the apex of the heart for inductively
coupled plasma mass spectrometry (ICP-MS) analysis of blood lead
level.
Analysis ICP-MS was  performed with an Agilent 7500ce ICP/MS
equipped with an octopole reaction system and a CETAC ASX-520
autosampler as previously described (Sobin et al., 2011a). Brieﬂy,
samples were introduced to the plasma through a MicroMist U-
series nebulizer (Glass Expansion, Australia) and a double-pass
quartz spray chamber (Agilent, Santa Clara, CA). Instrument param-
eters were: carrier gas, 0.78 L/min; makeup gas, 0.15 L/min; RF
power, 1420 W;  spray chamber temperature, 2 ◦C.
Certiﬁed whole blood standards (Le Center de Toxicologie du
Quebec) were analyzed to determine instrument reproducibility
and validate quantitation. Ten solutions were prepared for each
of two standards (4.00 and 6.59 g/dL) and each of those were
analyzed three times by ICP-MS. Standard concentrations were
chosen to approximate low blood Pb values of children in this study.
Blood standards were prepared as previously described (Sobin et al.,
2011b) (Agilent technical note #5988-0533EN). Brieﬂy, 5.58 mL of
water (18 M DI, Labconco WaterPro® PS Station, Kansas City, MO)
was placed in a polypropylene tube into which 300 L of whole
blood was  added, followed by addition of 60 L of aqueous internal
standard solution (100 ppb each germanium, yttrium and terbium
in 5% nitric acid, Fisher Optima) and 60 L of aqueous 10 ppm gold
in 3% hydrochloric acid (EMD Chemicals) solution. The ﬁnal dilu-
tion was twenty-fold, the ﬁnal internal standard concentration was
1 ppb and the ﬁnal gold concentration was 100 ppb. A six-point
external calibration curve was  prepared from a Pb stock solution in
1% nitric acid. ICP-MS standard solutions containing the elements
in 2% nitric acid were obtained from Inorganic Ventures (Chris-
tiansburg, VA). Samples were vortexed for a few seconds prior
to a one minute centrifugation at 2000 rcf and the supernatant
analyzed by ICP-MS. Blank solutions were analyzed after every
three samples throughout the analytical sequence and standard
check solutions were analyzed ﬁve times, interspersed through the
sequence. All samples produced signals in excess of the limit of
quantitation (i.e. ten-fold greater than the detection limit) for each
analyte.
2.3. Tissue processing
Animals were perfused transcardially with 10% sucrose followed
by phosphate-buffered 4% paraformaldehyde. Fixed kidneys were
removed and stored in the same ﬁxative at 4 ◦C for approximately
6 weeks. Kidneys were weighed and 1-mm cubes were cut from
the cortex, washed three times in buffer, post-ﬁxed in 1% osmium
tetroxide for one hour, washed three times in buffer, and embedded
in Polybed 812 (Polysciences, Inc., Warrington, PA). One female kid-
ney from the low-dose group was  not adequately perfuse-ﬁxed and
thus was  not used for morphometric analysis. Tissue was examined
via light and electron microscopy.
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.4. Podocyte number and glomerular volume via light
icroscopy: Study 1
Light microscopy methods were used to compare glomerular
olume, podocyte number and podocyte numerical density in three
roups (controls, 30 ppm and 330 ppm).
.4.1. Sectioning
Serial 1-mm thick sections were cut from one or two tis-
ue blocks per kidney using an EM UC7 ultramicrotome (Leica
icrosystems, Buffalo Grove, IL) ﬁtted with a Histo Jumbo diamond
nife (Diatome US, Hatﬁeld, PA). The ﬁrst section from a block with
o holes was saved to a glass slide and stained with 0.5% toluidine
lue. This slide was labeled 0. Subsequently, every 10th section
nd the adjacent section were saved to a new slide, stained with
oluidine blue and the slides labeled 10, 20, 30, etc. Twenty pairs of
ections were saved from each kidney and used for light microscopy
nalysis.
.4.2. Imaging
All imaging was conducted blind to experimental group and
lind to mouse blood lead level. A BX51 microscope with DP 71
igital camera and DB Controller software (Olympus America, Inc.,
ypress, CA) was used to obtain images. A map  of all the glomeruli
resent in the section on slide 0 was drawn using the 10× objec-
ive lens. (Glomeruli on slide 0 were necessarily partial objects and
ere not used for morphometry). Next, the two sections on slide
0 were examined and compared to slide 0. All newly appearing
lomeruli were identiﬁed, mapped, numbered sequentially and
maged using the 100× objective lens (NA = 1.40). These glomeruli
nd new glomeruli appearing on subsequent slides were imaged
sing the subsequent pairs of sections until each glomerulus disap-
eared. Ten glomeruli were imaged per mouse. A stage micrometer
as imaged and used to validate magniﬁcation. Image ﬁles were
ransferred to an Apple iMac Computer and viewed on a 24 in. mon-
tor using Photoshop software (Adobe Systems, Inc., San Jose, CA).
 Photoshop window magniﬁcation of 67% was used when making
easurements.
.4.3. Podocyte number
The number of podocytes per glomerulus was counted using theractionator/disector method (Bai and Basgen, 2011; Nyengaard,
999). Podocyte nuclei were counted as a surrogate for the num-
er of podocytes assuming one and only one nucleus per podocyte.
sing the two images of a glomerulus from each pair of sections,
ig. 1. Disector sections used for counting podocytes. The two  images from adjacent 1-m
oth  sections were not counted (red dots). Proﬁles from podocyte nuclei present in the s
−s and were used to calculate podocyte number. Scale bar = 10 m. Letters 225 (2014) 48– 56
the number of proﬁles from a podocyte nucleus seen in the ﬁrst
section (the sample section) but not in the adjacent section (the
look-up section) was counted (Fig. 1). This was repeated until all
pairs of images (levels) from a glomerulus were analyzed. Podocyte
number was calculated using the equation:
Npodocyte = 10 ×
∑
Q−
where 10 was  the reciprocal of the fraction (1/10) of the glomerulus
sampled.
∑
Q− is the sum over all the section pairs from a glomeru-
lus of nuclear proﬁles from podocytes seen in the sample sections
but not in the look-up sections. Ten glomeruli per kidney were ana-
lyzed and the average number of podocytes per glomerulus was
calculated.
2.4.4. Glomerular volume
Glomerular volume was  estimated using the Cavalieri Princi-
ple (Bai and Basgen, 2011; Nyengaard, 1999). The glomerulus was
deﬁned as the minimal string polygon surrounding the glomerular
tuft (Fig. 2). The sample section image from each pair of images from
a glomerulus was  used to estimate glomerular volume. Using the
Layers function of Photoshop, a grid of points was  randomly super-
imposed over each sample section image and the number of grid
points touching the glomerulus was  counted (Fig. 2). Glomerular
volume was calculated using the equation
Vglomerulus = 10 ×
∑
P × (d/mag)2m3
where 10 is the distance between the sample sections in m,
∑
P is
the sum of grid points counted touching the glomerulus in all sam-
ple sections images from the glomerulus, d is the distance between
the points on the grid in m,  and mag  is the magniﬁcation of the
images. Volume was  measured using 10 glomeruli from each kid-
ney and the average glomerular volume for a mouse calculated.
2.4.5. Podocyte numerical density
The numerical density of podocyte per glomerular volume was
calculated by dividing the number of podocytes counted in a
glomerulus by the glomerular volume.
2.5. Volume of glomerular components via electron microscopy:
Study 2
Differences between controls and low-dose mice in glomerular
volume found in Study 1 necessitated further detailed analysis and
m thick sections formed a disector pair. Proﬁles from podocyte nuclei present in
ample section but not present in the look-up section (red arrows) were counted as
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Fig. 2. Six images (10 m apart) from a glomerulus used to measure glomerular volume. The glomerulus was deﬁned as the minimal string polygon surrounding the
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slomerular tuft as shown in Section 20. A counting grid was  randomly placed over 
lomerular volume was  calculated by multiplying the distance between sections (10
y  the area represented by 1 grid point. Scale bar = 10 m.
omparison of glomerular components of controls and low-dose
nimals via electron microscopy.
.5.1. Sectioning
For electron microscopy analysis, a single 1-m thick section
rom each of several tissue blocks was saved and stained with tolu-
dine blue. Using these scout sections, whole glomerular proﬁles at
east one large glomerular diameter from the edge of the block were
elected for thin sectioning. Using the same ultramicrotome ﬁt-
ed with an Ultra diamond knife (Diatome US), silver–gold sections
ere cut, placed on formvar-coated single slot grids and stained
ith uranyl acetate and lead citrate.
.5.2. Imaging
All imaging was conducted blind to experimental group and
lind to mouse blood lead level. A JEM1200-EX electron micro-
cope (JEOL USA, Inc., Peabody, MA)  ﬁtted with a digital camera and
igitalMicrographs software (Gatan, Inc., Pleasanton, CA) was used
o obtain EM images of complete glomerular proﬁles at an initial
agniﬁcation of 3000×. For larger glomerular proﬁles, two to four
mages were needed to cover the entire proﬁle. Image ﬁles were
ransferred to an Apple iMac Computer and viewed on a 24 in. mon-
tor (Apple, Inc., Cupertino, CA) using Photoshop software (Adobe
ystems, Inc.) and a window magniﬁcation of 100% was used for all
easurements.
.5.3. Volume density of glomerular components
The volume densities of glomerular components were estimated
sing the Delesse Principle (Weibel, 1979) on the EM images.
he glomerulus was divided into four components: podocyte,
esangium, capillary lumen (including endothelial and circu-
ating cells), and remainder components including Bowman’s
pace, glomerular basement membrane, and non-resolvable tis-
ue (Fig. 3A). The glomerulus was again deﬁned as the minimalmage and the number of grid points falling on the glomerular proﬁle was counted.
y the sum of the points counted over all the glomerular proﬁles, and then multiplied
string polygon surrounding the glomerular tuft (Fig. 3B). A count-
ing grid was randomly superimposed over the glomerular image;
the number of grid points touching each of the four components
was counted (Fig. 3B). The volume density of a component per
glomerulus was  calculated using the equation:
Vv(Component X/glomerulus)  = PComponent X/
∑
Pfour components
where X represents a component, either podocyte, mesangium,
capillary lumen, or remainder and
∑
Pfour components is the sum of
the points touching all four components. Ten glomerular proﬁles
were measured per kidney and used to calculate the kidney mean
for each component.
2.5.4. Volume of glomerular components
The volume of each individual glomerular component was cal-
culated by multiplying the component volume density by the
mean glomerular volume. For example, to calculate the volume of
mesangium within a glomerulus:
Volumemesangium = Vv(Mesangium/glomerulus)
× Glomerular volume, m3
The volume of each glomerular component was calculated using
each respective volume density.
2.6. Statistical analysis
SAS Version 9.2 statistical software was used for all analyses.
Entered data were checked for accuracy and distribution proper-
ties; no outliers were identiﬁed and all data were included for
analysis. For Study 1, blood lead level, body weight and kidney
weight; and glomerular volume, podocyte volume density and
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Fig. 3. Electron microscopy image used to measure volume density of glomerular
components. (A) Image of glomerular proﬁle showing podocytes (Podo), mesangium
(Mes), capillary lumen (CL), and Bowman’s space (BM). (B) Image of a glomerular
proﬁle with counting grid. Glomerulus was deﬁned as the minimal string polygon
surrounding the glomerular tuft. The number of grid points falling on each of the
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tests of least square means showed that glomerular volume of
T
Mour  deﬁned glomerular components was counted and used to calculate the volume
ensity of each component. Scale bar = 10 m.
odocyte number were compared using a 3 (group) × 2 (sex) gen-
ral linear model ANOVA, which also indicated amount of variance
xplained (R2) for each model. For Study 2, podocyte, mesangium,
apillary lumen (including endothelial and circulating cells), and
emainder component volume differences were compared using a
 (group) × 2 (sex) general linear model ANOVA. Type III sum of
quares was used to determine statistically signiﬁcant differences
p < .05); post hoc tests of marginal means (“least square means”)
able 1
ean (SD) of physiological characteristics of 28 day old C57BL6/J mice with and without 
Controls Low
Males (n = 6) Females (n = 6) Mal
Blood lead level (g/dL)a 0.03 (0.01) 0.03 (0.01) 3.6
Body  weight (g)b 14.7 (1.3) 13.6 (1.3) 13.6
Kidney  weight (mg)b 0.11 (0.01) 0.10 (0.02) 0.0
a ANOVA < 0.01.
b ANOVA < 0.05. Letters 225 (2014) 48– 56
were conducted for all signiﬁcant models. (Least square means are
the means of each subgroup corrected for all other factors in the
model.)
3. Results
3.1. Clinical characteristics
Table 1 shows the means and standard deviations for blood lead
level, body weight and kidney weight, by exposure group and sex
at sacriﬁce (PND 28). Lead treatments yielded the expected group
differences in blood lead level as determined by ICP-MS (F = 134.91,
p < .01; R2 = 0.96). Differences were accounted for by independent
effects of group (Type III SS, F = 331.77, p < .01) and sex (Type III
SS, F = 5.85, p = .02). Within treated groups, blood lead levels were
higher in males. The group × sex interaction was not signiﬁcant.
Body weight at sacriﬁce differed (F = 4.21, p < .01; R2 = 0.41),
accounted for by independent effects of group (Type III SS, F = 3.64,
p = .04) and sex (Type III SS, F = 13.0, p < .01); the group × sex inter-
action was not signiﬁcant. Least square means for body weight of
low-dose (12.89 g) and high-dose (12.92 g) animals did not differ;
the body weight for both experimental groups was less than that
of controls (14.12 g) (p = .03 for both comparisons). Also, females
(12.54 g) weighed less than males (14.08 g) (p < .01). The interaction
of group × sex was not signiﬁcant.
Kidney weight also differed (F = 3.27, p = .02; R2 = 0.37), again
accounted for by independent effects of group (Type III SS, F = 3.60,
p = .04) and sex (Type III SS, F = 7.21, p = .01) with no interaction
effect. Post hoc tests of least squared means revealed that group
differences in kidney weight were accounted for by reduced kidney
weight among only the low-dose animals (0.09 g) (p = 01) (Table 1).
Kidney weights of control (0.10 g) and high-dose (0.10 g) animals
did not differ.
3.2. Podocyte number and glomerular volume: Study 1 (light
microscopy)
Table 2 shows the means and standard deviations for podocyte
number, glomerular volume, and podocyte numerical density.
3.2.1. Podocyte number
The mean number of podocyte Q−s counted per mouse was  136
(range: 102–169). Podocyte number did not differ among groups.
3.2.2. Glomerular volume (m3)
The mean number of proﬁles (levels) measured per glomeru-
lus was 5.4 (range: 3–8) with a mean of 374 (range: 313–479)
grid points counted per mouse. Glomerular volume differed among
groups (F = 5.20, p < .01; R2 = 0.47) and differences were accounted
for by exposure group (Type III SS, F = 12.58, p < .01). Post hoclow-dose animals (86,898 m3) was  greater than that of controls
(72,215 m3) (p < .01) and high dose animals (77,328 m3) (p < .01)
(Fig. 4).
lead exposure.
-dose High-dose
es (n = 6) Females (n = 5) Males (n = 6) Females (n = 6)
3 (0.71) 2.74 (0.36) 16.02 (3.25) 13.35 (1.31)
 (0.6) 12.2 (1.2) 13.9 (1.5) 11.9 (1.5)
9 (0.01) 0.09 (0.01) 0.11 (0.01) 0.09 (0.02)
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Table 2
Mean (SD) of podocyte number, glomerular volume and podocyte numerical density in young C57BL6/J mice with and without lead exposure (via light microscopy at 100×).
Controls Low-dose High-dose
Males (n = 6) Females (n = 6) Males (n = 6) Females (n = 5) Males (n = 6) Females (n = 6)
Podocyte number 70(9) 65(8) 
Glomerular volume (m3) 73,513 (6392) 70,916 (4960) 
Podocyte numerical density (×10−6 m−3) 957 (154) 925 (99) 
F
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mean = 27,216; SE = 939) (Fig. 5C).
T
Mig. 4. Glomerular volume. Graph shows individual mouse glomerular volume data
t  post-natal day 28 for the control, lose-dose, and high-dose groups.  = male;
 = female.
.2.3. Podocyte numerical density
Podocyte volume density did not differ among groups. It was
oted that the R2 for this model was 0.24, and the Type III SS for the
roup effect was signiﬁcant (F = 3.77, p = .03), however the model F
as not signiﬁcant (F = 1.86, p = .13). (Glomerular density tended to
e reduced only among low-dose animals.)
.3. Volume of glomerular components: Study 2 (electron
icroscopy)
To examine the possible sources of increased glomerular vol-
me  in low-dose lead exposed animals, densities and volumes of
odocytes, capillary lumen (including endothelial and circulating
ells); mesangium; and remainder components (including Bow-
an’s space, glomerular basement membrane, and non-resolvable
able 3
ean (SD) of glomerular component volume density and volume in young C57BL/6J mice
Controls 
Males (n = 6) Femal
Volume density
Podocyte 0.319 (0.033) 0.314 
Mesangium 0.165 (0.043) 0.196 
Capillary  lumena 0.388 (0.031) 0.365 
Remainderb 0.128 (0.024) 0.125 
Volume
Podocyte (m3) 23,416 (2473) 22,311
Mesangium (m3) 12,173 (3608) 13,882
Capillary lumena (m3) 28,632 (3923) 25,802
Remainderb (m3) 9419 (1811) 8844 (
a Including endothelial and circulating cells.
b Including Bowman’s space, glomerular basement membrane, and non-resolvable tiss70 (7) 69 (5) 67 (3) 71 (9)
85,744 (4547) 88,051 (11,312) 78,648 (7367) 76,009 (6902)
828 (69) 800 (116) 862 (61) 940 (142)
tissue) were estimated for low-dose lead exposed and control ani-
mals using electron microscopy. Table 3 shows the means and
standard deviations for each of these components by group and
sex.
3.3.1. Glomerular component volume densities
The mean number of grid points counted per animal was 632
(range: 324–961). Control and lead-exposed animals did not dif-
fer with regard to volume density of podocytes; capillary lumen;
mesangium; and remainder components (Table 3).
3.3.2. Glomerular component volumes
3.3.2.1. Podocyte volume. Podocyte volume did not differ between
groups. It was noted however that while the model F did not reach
signiﬁcance (F = 2.39, p = .10) the Type III SS for the main effect group
(F = 6.82, p = .02) was  signiﬁcant (R2 = 0.27). The broad variability of
podocyte volume values among the exposed group showed that a
larger sample size might be needed to statistically detect differ-
ences in podocyte volume (Fig. 5A).
3.3.2.2. Mesangial volume. Mesangial volume differed between
groups (F = 5.12, p < .01; R2 = 0.45) accounted for by independent
effects of exposure group (Type III SS F = 10.97, p < .01) and sex
(F = 4.85, p < .05). Mesangial volume was  larger in low-dose ani-
mals (LS mean = 16,825, SE = 829) as compared with controls
(13,027, SE = 791). Also, regardless of exposure, mesangial vol-
ume  in females (LS mean = 16,189, SE = 830) was greater than in
males (LS mean = 13,663, SE = 791) (Fig. 5B). The interaction of expo-
sure × sex was  not signiﬁcant.
3.3.2.3. Capillary volume. Capillary lumen volume, including
endothelial and circulating cells, differed between groups (F = 8.46,
p < .01; R2 = 0.57) accounted for by only exposure (Type III SS
F = 15.05, p < .01). Capillary lumen volume was larger in low-dose
animals (LS mean = 33,671; SE = 984) as compared with controls (LS3.3.2.4. Remainder component volume. The “remainder compo-
nent” did not differ between groups (F = 0.99, p = .42; R2 = 0.14).
 with and without lead exposure determined via electron microscopy at 3000×.
Low-dose
es (n = 6) Males (n = 6) Females (n = 5)
(0.024) 0.307 (0.021) 0.301 (0.025)
(0.036) 0.177 (0.027) 0.212 (0.021)
(0.008) 0.398 (0.016) 0.378 (0.016)
(0.027) 0.122 (0.019) 0.108 (0.012)
 (2640) 26,306 (2440) 26,650 (5309)
 (2783) 15,154 (2417) 18,496 (1561)
 (2056) 34,134 (1819) 33,208 (4650)
1821) 10,427 (1702) 9395 (783)
ue.
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Fig. 5. Glomerular component volumes. Graph shows individual mouse data for
podocyte volumes (Panel A), mesangial volumes (Panel B), and capillary volumes
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are needed to examine this possibility.Panel C) at post-natal day 28 for the control and lose-dose groups.  = male;
 = female.
. Discussion
Hundreds of child and adult studies have examined the effects
f lead exposure on organs and bodily systems. Very few studies
owever examined effects associated with chronic low-level expo-
ure yielding very low blood lead levels. One such study showed
hat among 769 children and adolescents with blood lead levels
etween 1.6 and 4.1 g/dL, cystatin-C estimated glomerular ﬁltra-
ion rate was inversely associated with blood lead level (Fadrowski
t al., 2010) suggesting a dose response relationship even at lowest
evels of exposure. These ﬁndings may  have profound implications
or the health and development of large numbers of low-income
hildren. In our studies of 648 school children between the ages
f 5 and 12 years and living in lower socioeconomic conditions,
pproximately 70% had blood lead levels of 1.6 g/dL or higher
unpublished data). Other clinical studies have suggested that large
umbers of low-income children in particular have blood lead lev-
ls greater than 1.6 g/dL suggesting the need to understand the
ffects on kidney development of low level lead exposure yielding
ow blood lead levels.
In the animal literature, only six studies thus far have examined
ffects of early chronic lead exposure yielding low blood lead lev-
ls that overlap those of high-risk children (Azzaoui et al., 2009;
erguson and Bowman, 1990; Kasten-Jolly et al., 2012; Leasure
t al., 2008; Reiter et al., 1975; Sobin et al., 2013); only one of
hose studied effects of low-level lead in young animals (Sobin
t al., 2013). In the current studies, using light microscopy and
nbiased stereological methods, we found that pre-adolescent lead
xposed mice with blood lead levels between 2.4 and 4.7 g/dL had Letters 225 (2014) 48– 56
increased glomerular volume as compared with controls and high
dose animals (with blood lead levels between 11.7 and 20.3 g/dL).
Using electron microscopy and unbiased stereological methods,
we found that increased glomerular volume was  attributable to
increased mesangial volume and increased capillary volume, but
not increased podocyte volume (“remainder component” volumes
also did not differ).
Growth hormones, notably, VEGF and TGF-ß play an integral role
in the normal development of the glomerulus (de Vriese et al., 2001;
Liu et al., 1999), and speciﬁcally in the development of glomerular
capillaries. Increased growth factors within the glomerulus have
been shown to increase volume of the glomerulus, mesangium, and
capillaries (de Vriese et al., 2001; Flyvbjerg et al., 2002); and growth
hormone levels are increased in diabetic nephropathy. Increased
growth hormone levels in animal models of kidney disease resulted
in abnormal glomerular capillary and mesangial growth (Flyvbjerg
et al., 2002).
Speciﬁcally with regard to lead exposure, Hossain et al. used
microarray analysis to identify lead-sensitive genes in fetal human
astrocytes. In lead exposed animals the growth hormone VEGF
was one of the most highly expressed genes examined (Hossain
et al., 2000). In follow-up studies neonatal rats exposed to lead had
a two-fold increase of VEGF expression in cerebellum as well as
microvascular hemorrhage and increased vascular permeability to
serum albumin (Hossain et al., 2004). In another set of studies Zus-
cik and colleagues showed that lead exposure enhanced the effect
of TGF- on chondrogenesis in murine limb bud mesenchymal cells
(Zuscik et al., 2007).
With regard to the current ﬁndings, further studies are needed
to examine whether increased capillary and mesangial growth in
the low-dose animals induced overproduction of VEGF and TGF-
resulting in new glomerular capillary formation and mesangial
expansion. Also, whether the structural changes observed in
pre-adolescent mice predispose animals to perhaps abnormal
GFR followed in adulthood by glomerulosclerosis needs to be
examined.
In the current studies, structural changes to the glomerulus were
unique to animals with blood lead levels between 2.4 and 4.7 g/dL;
no changes to the glomerulus were observed in animals with blood
lead levels between 11.7 and 20.3 g/dL. Replication and exten-
sion of these studies may  eventually help to reveal why or how low
level but not higher level lead exposure causes structural hyper-
trophic changes in the developing kidney. Additional studies are
needed to examine, for example, whether blood lead levels above
10 g/dL trigger protective mechanisms that assist in sequester-
ing lead in bone, thereby rendering the absorbed lead unable to
alter growth hormone levels. Complementary studies could exam-
ine whether lead sequestration is less likely in cases of low-level
exposure, resulting in higher levels of circulating lead that are per-
haps sufﬁcient to stimulate overproduction of growth hormones
and thus resulting in glomerular hypertrophy, abnormal GFR, and
perhaps kidney disease in adulthood.
Podocytes play an important role in regulating the ﬁltration of
molecules through the glomerular ﬁltration surface. Distortion in
the architecture of the podocytes and later loss of podocytes is asso-
ciated with the leakage of some proteins into the urine, another
marker of kidney disease progression (Greka and Mundel, 2012). In
this study of pre-adolescent animals, podocyte number and volume
did not differ among groups. It is possible that the etiologic effects
of hyperﬁltration and deceased GFR on the health of podocytes is of
relatively long duration, thus changes in podocyte number and vol-
ume  might not be measurable until adulthood. Additional studiesIn addition to the structural differences observed, only the
low-dose animals had signiﬁcantly reduced kidney weight (both
lead exposed groups had reduced body weight as compared with
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ontrols). If replicated this ﬁnding may  provide an additional
nique marker of low-level lead induced kidney pathology. Addi-
ional studies are needed to determine whether reduced kidney
eight in the low-dose animals reﬂects an early stage of a disease
rocess that diminishes normal tissue density.
Our ﬁndings of structural hypertrophic changes in low level
ead exposed animals may  be broadly consistent with changes that
ccur in the early stages of kidney disease. An increase in glomeru-
ar volume is an early marker of some kidney diseases (Hattori
t al., 1993) and has been simulated in murine models of kidney
isease (Suzuki et al., 2005). Glomerular hypertrophy results from
ncreased glomerular capillary volume and surface area, and also
ncreased mesangial volume (Hirose et al., 1980; Peppa et al., 2006).
yengaard and Rasch (1993) have shown that such increases in the
iabetic rat are the result of an increase in the number of capillar-
es within the glomerulus, which in turn increases the glomerular
ltration surface and thus hypertrophy. These ﬁndings require
eplication. It will also be important to conduct long-term follow-
p studies to determine whether in utero lead exposure decreases
he number of glomeruli which may  in turn predict hypertension
nd glomerular sclerosis in later adulthood (following those devel-
pmental changes that may  have had few clinical sequelae early in
ife).
More generally speaking, this study attempted to increase
he relevance of ﬁndings to the problem of child low-level lead
xposure in several ways. The exposure protocol was  developed
o yield a relatively narrow range of blood lead levels in the
ow-level exposure group that overlapped approximately 60% of
he low-income children studied. Moreover, children in clinical
ow-level lead studies have typically been of pre-adolescent age
hus in these studies animals were exposed from birth to PND 28,
hich is immediately prior to the onset of puberty. ICP-MS analysis
f blood samples taken at sacriﬁce were used to conﬁrm that our
ead treatments (30 ppm and 330 ppm) produced a low-dose group
ith blood lead levels that overlapped those of a majority of our
ow-income child study participants, and a positive control group
ith signiﬁcantly higher blood lead levels. Kidneys were harvested
mmediately upon sacriﬁce, sectioned and analyzed via light and
lectron microscopy and all studies were conducted blind to group
nd blood lead level. The hallmark of progressive kidney disease
s a decrease in GFR while the early stages of some nephropathies
nclude temporary increases in GFR, that is, hyperﬁltration (Jerums
t al., 2010). In this study, kidney function was not directly assessed;
his limitation is being addressed in ongoing studies. These studies
sing unbiased designed-based stereological methods detected
or the ﬁrst time early glomerular structural changes in pre-
dolescent mice that may  predict progression to kidney failure in
dulthood.
. Conclusions
Structural markers of kidney maldevelopment including
lomerular hypertrophy, capillary volume increase and mesangial
xpansion, and reduced kidney weight, are evident in a mouse
odel examining the effects on pre-adolescent kidney of chronic
evelopmental low-level lead exposure yielding blood lead levels
etween 2.4 and 4.7 g/dL. The ﬁndings raise important questions
egarding the mechanisms that might explain effects at lowest but
ot higher levels of lead exposure. Additional studies are needed to
xamine the mechanistic relationships between lead exposure and
hese early structural changes and to examine whether these early
hanges are in fact markers of later kidney disease. Studies of the
ssociations between structural and functional markers of disease
re also needed. Given the large numbers of low-income minor-
ty children at high risk of chronic developmental low-level lead Letters 225 (2014) 48– 56 55
exposure, these ﬁndings may  suggest early clues regarding one
possible source of kidney disease in minority populations.
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